Le Lézard
Classified in: Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024


Outset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the first quarter of 2024 after the close of trading on Wednesday, May 8, 2024.

On the same day, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Nabeel Ahmed, Chief Financial Officer, will host a conference call to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) on Wednesday, May 8, 2024. Those interested in listening to the conference call may do so by registering online. Once registered, participants will receive dial-in numbers and a unique pin to join the call. Participants are encouraged to register more than 15 minutes before the start of the call. A live and archived webcast of the event will be available on the "Investors" section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.


These press releases may also interest you

at 14:30
Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") , today announced that it has filed an application with the Supreme Court of British Columbia for summary determination in its ongoing litigation with Verano...

at 14:28
First Horizon Corporation  is proud to announce its participation in the American Bankers Association (ABA) Foundation's "Teach Children to Save Day," directly providing financial literacy skills to more than 7,000 students. In April, First Horizon...

at 14:19
Nelumbo Inc., a pioneering surface and coating technology company, proudly announces that it is partnering with Daylight Foods on a California Energy Commission project to deploy Nelumbo's anti-ice technology, IceNein®. Daylight Foods is a prominent...

at 14:15
Vista Gold Corp. ("Vista" or the "Company") today announced its unaudited financial results for the quarter ended March 31, 2024, with cash totaling $11.9 million at quarter-end. All dollar amounts in this press release are in U.S. dollars....

at 14:10
Empower is announcing record first-quarter earnings achieved as of March 31, 2024, through business growth and sales momentum in its Workplace Solutions and Personal Wealth units. The company now administers over $1.6 trillion in assets for 18.6...

at 14:00
Hyperquake, the independent creative strategy, branding and experience design agency, is very proud to announce its immediate acquisition of Brooklyn-based Potion. Launched in 2005, under the leadership of Founder Phillip R. Tiongson, Potion has...



News published on and distributed by: